A comprehensive analysis of a database comprising 290 iCCA patients, alongside tumor tissue immunohistochemistry, revealed that CTLA-4+ TILs and PD-L1+ TILs can independently predict tumor recurrence and OS in iCCA patients following surgical resection (151). This evidence concerns the gene CTLA4 and neoplasm.